Galecto (GLTO) Competitors $3.48 +0.09 (+2.50%) Closing price 03:45 PM EasternExtended Trading$3.48 0.00 (0.00%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLTO vs. QTTB, LPCN, CING, MTEX, GELS, CARM, MRKR, CTXR, RVPH, and PMNShould you be buying Galecto stock or one of its competitors? The main competitors of Galecto include Q32 Bio (QTTB), Lipocine (LPCN), Cingulate (CING), Mannatech (MTEX), Gelteq (GELS), Carisma Therapeutics (CARM), Marker Therapeutics (MRKR), Citius Pharmaceuticals (CTXR), Reviva Pharmaceuticals (RVPH), and Promis Neurosciences (PMN). These companies are all part of the "pharmaceutical products" industry. Galecto vs. Its Competitors Q32 Bio Lipocine Cingulate Mannatech Gelteq Carisma Therapeutics Marker Therapeutics Citius Pharmaceuticals Reviva Pharmaceuticals Promis Neurosciences Q32 Bio (NASDAQ:QTTB) and Galecto (NASDAQ:GLTO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk. Which has better earnings and valuation, QTTB or GLTO? Galecto has lower revenue, but higher earnings than Q32 Bio. Q32 Bio is trading at a lower price-to-earnings ratio than Galecto, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQ32 Bio$1.16M34.92-$47.73M-$4.94-0.67GalectoN/AN/A-$21.44M-$15.53-0.22 Does the media favor QTTB or GLTO? In the previous week, Galecto had 3 more articles in the media than Q32 Bio. MarketBeat recorded 4 mentions for Galecto and 1 mentions for Q32 Bio. Q32 Bio's average media sentiment score of 0.00 beat Galecto's score of -0.67 indicating that Q32 Bio is being referred to more favorably in the media. Company Overall Sentiment Q32 Bio Neutral Galecto Negative Which has more risk & volatility, QTTB or GLTO? Q32 Bio has a beta of -0.07, meaning that its stock price is 107% less volatile than the S&P 500. Comparatively, Galecto has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Do analysts recommend QTTB or GLTO? Q32 Bio presently has a consensus price target of $12.17, indicating a potential upside of 266.47%. Galecto has a consensus price target of $10.00, indicating a potential upside of 186.94%. Given Q32 Bio's higher possible upside, analysts clearly believe Q32 Bio is more favorable than Galecto.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Q32 Bio 0 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Galecto 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in QTTB or GLTO? 31.3% of Q32 Bio shares are held by institutional investors. Comparatively, 14.2% of Galecto shares are held by institutional investors. 40.0% of Q32 Bio shares are held by insiders. Comparatively, 10.8% of Galecto shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is QTTB or GLTO more profitable? Galecto's return on equity of -98.27% beat Q32 Bio's return on equity.Company Net Margins Return on Equity Return on Assets Q32 BioN/A -447.33% -59.77% Galecto N/A -98.27%-84.29% SummaryQ32 Bio beats Galecto on 8 of the 14 factors compared between the two stocks. Get Galecto News Delivered to You Automatically Sign up to receive the latest news and ratings for GLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GLTO vs. The Competition Export to ExcelMetricGalectoMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.50M$2.96B$5.56B$9.04BDividend YieldN/A2.42%5.25%4.03%P/E Ratio-0.2221.1127.1820.14Price / SalesN/A284.26439.56137.26Price / CashN/A42.7337.5058.41Price / Book0.327.748.085.60Net Income-$21.44M-$54.96M$3.16B$248.43M7 Day Performance1.01%6.04%3.77%5.15%1 Month Performance3.72%4.47%3.90%7.62%1 Year Performance-72.18%6.12%34.22%21.56% Galecto Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GLTOGalecto3.2497 of 5 stars$3.49+2.5%$10.00+186.9%-73.1%$4.50MN/A-0.2240News CoverageGap DownQTTBQ32 Bio2.2529 of 5 stars$1.49+2.8%$12.17+716.6%-92.6%$17.69M$1.16M-0.3039Gap UpLPCNLipocine1.6298 of 5 stars$3.16-4.0%$9.00+184.8%-58.4%$17.60M$11.20M-3.1010CINGCingulate2.991 of 5 stars$4.07+0.5%$26.00+538.8%+1,116.8%$17.19MN/A-0.4820News CoverageMTEXMannatech0.3099 of 5 stars$9.35+3.9%N/A+18.8%$17.11M$117.87M-93.50250High Trading VolumeGELSGelteqN/A$1.73-4.4%N/AN/A$17.08M$100K0.00N/AGap UpCARMCarisma Therapeutics2.4295 of 5 stars$0.39-2.2%$1.93+391.6%-64.8%$16.74M$19.63M-0.2520Gap UpMRKRMarker Therapeutics3.7017 of 5 stars$1.53+4.8%$13.17+760.6%-63.4%$16.52M$6.59M-1.1560CTXRCitius Pharmaceuticals2.4427 of 5 stars$1.59+3.9%$53.00+3,233.3%-89.5%$16.27MN/A0.0020Gap DownHigh Trading VolumeRVPHReviva Pharmaceuticals2.4706 of 5 stars$0.38+12.9%$9.00+2,261.6%-67.5%$16.20MN/A-0.485Gap UpHigh Trading VolumePMNPromis Neurosciences2.8343 of 5 stars$0.48+0.7%$4.50+830.1%-82.4%$15.70MN/A-9.685Gap Up Related Companies and Tools Related Companies Q32 Bio Competitors Lipocine Competitors Cingulate Competitors Mannatech Competitors Gelteq Competitors Carisma Therapeutics Competitors Marker Therapeutics Competitors Citius Pharmaceuticals Competitors Reviva Pharmaceuticals Competitors Promis Neurosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GLTO) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galecto With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.